The company’s consolidated revenue from operations rose 14.4% year-on-year to ₹4,255 crore from ₹3,719 crore in the year-ago quarter, driven by higher volumes, which offset lower realisations.
The consolidated Earnings before interest, tax, depreciation and amortisation (EBITDA) declined 14.5% to ₹555 crore during the quarter compared with ₹649 crore in the same period last year. The decline was primarily due to lower realisations in overseas subsidiaries, particularly US exports to Southeast Asia markets.
ALSO READ | Tata Chemicals shares in focus after Q4 hit by impairment, weak soda ash realisations
The consolidated EBITDA margin stood at 13% in the June quarter, down from 17.5% a year earlier.
The company’s net debt, excluding leases, stood at ₹5,692 crore as of June 30, 2026. Tata Chemicals said net debt declined compared with the previous quarter due to monetisation of assets.
On a standalone basis, Tata Chemicals reported revenue from operations of ₹1,281 crore in Q1FY27, up 10% compared with Q1FY26, driven by higher volumes and realisation.
Standalone EBITDA stood at ₹364 crore, registering a 35% year-on-year growth, supported by higher volumes and realisations, partially offset by an increase in costs. Profit after tax (PAT) from continuing operations stood at ₹343 crore, up 12% compared with Q1FY26.
ALSO READ | Explained — Why Tata Chemicals shares surged as much as 11% in a weak market
R Mukundan, Managing Director & CEO, Tata Chemicals Limited, said, “During Q1FY27, amidst a challenging external environment, the company delivered a resilient performance, supported by higher sales and production volumes, strong operating efficiencies and disciplined cost management. However, exports from the USA to Southeast Asia remained under pressure due to persistent unremunerative soda ash pricing.
Financial results of the Company are aligned with the LIFE (Living, Industrial, Farm Essentials) strategy, reshaping portfolio towards sustainability-led, application-focused businesses while maintaining strength in core capabilities. Thus, transitioning the portfolio to non-cyclical segments, with focused capital allocation to build a structurally resilient growth platform with stable earnings.”
Mukundan said the outlook for the Living Essentials segment remains positive, supported by premiumisation in food, feed, pharma and beverages. Core products such as salt and bicarbonates are expected to deliver stable growth, while prebiotics are likely to grow faster due to rising health and wellness consumption trends.
ALSO READ | Tata Chemicals Q2 profit falls 60% to ₹77 crore on lower realisations, UK reconfiguration
For Industrial Essentials, mainly soda ash, Mukundan said the near-term outlook remains challenging due to global oversupply, weak demand conditions and excess industry capacity. He added that geopolitical tensions and elevated energy, raw material and freight costs continue to put pressure on margins and realisations.
On Farm Essentials, mainly Rallis, Mukundan said India’s farm sector outlook remains moderately positive, supported by improved irrigation, technology adoption, government initiatives and resilient rural demand. However, he noted that monsoon variability, potential El Niño conditions and higher input costs remain key risks to agricultural output.
Shares of Tata Chemicals Ltd ended at ₹698.60, up by ₹14.10, or 2.06%, on the BSE.
ALSO READ | Tata Chemicals arm to buy 100% stake in Singapore-based Novabay for €25 million
